1Chaves F, Tierno B, Xu DS, et al Ncgulrophil volume dislribution width: a hey, automated hematologic parameter for acute infection [J]. Arch Pathol Lab Med ,2006,130( 3 ) :378-380.
2Chaves F,Tierno B, Xu DS. Quantitative determination of negutrophil VCS parameters by the Coulter automated hematology analyzer: new and reliable indieators tor acute bacterial infection [ J ]. Am J Clin Pathol,2005,124 (3) : 440-444.
3Tefferi A, Vardiman JW. Classification and diagnosis of myeloprolifer- ative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms [ J ]. Leukemia, 2008, 22 ( 1 ) : 14-22.
4Campbell PJ, Scott LM, Buck G, et al. Definition of subtypes of es- sential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status : a prospective study [ J ]. Lancet, 2005, 366(9501 ) :1945-1953.
5Antonioli E, Guglielmelli P, Pancraszi A. Clinical implications of the JAK2 V617F mutation in essential thrombocytbemia [ J ]. Leuke- mia, 2005,19 (10) : 1847-1849.
7Swerdlow SH, Campo E, Harris NL, et al. (2008) World Health Organization classification of tumours of haematopoietic and lymphoid tissues[ M]. IARC, Lyon, 2008:40-49.
8Spivak JL. Narrative review : thrombocytosis, polycythemia vera, and JAK2 mutations : the phenotypic mimicry of chronic myeloproliferation [J]. Ann Intern Med, 2010, 152(5) :300-306.
9Wadleigh M, Tefferi A. Classification and diagnosis of myeloprolifer- ative neoplasms according to the 2008 World Health Organization cri- teria[J]. Int J Hematol, 2010, 91 (2) :174-179.
10Thiele J, Kvasnicka HM, Vardiman J. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl[J]. Best Pract Res Clin Haematol, 2006,19(3) :413-437.